InsidersTradesSigma
Explore the full record of transactions filed by Jones David Scott, Vice-Président Senior et Directeur Commercial. Officer active across 1 companies, notably EyePoint Pharmaceuticals, Inc.. In total, 3 reports have been recorded. The latest transaction was filed on 28 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
David Scott Jones serves as Senior Vice President and Chief Commercial Officer at EyePoint Pharmaceuticals, Inc. He is responsible for commercial strategy and managing customer relationships. His role includes implementing strategies to increase sales and market share for the company.